Literature DB >> 7653439

Significance of location (anterior versus inferior) and type (Q-wave versus non-Q-wave) of acute myocardial infarction in patients undergoing percutaneous transluminal coronary angioplasty for postinfarction ischemia.

F K Welty1, M A Mittleman, S M Lewis, R W Healy, S J Shubrooks, J E Muller.   

Abstract

Predictors of increased risk for recurrent cardiac events and death after acute myocardial infarction include postinfarction myocardial ischemia, anterior location of the infarct, and non-Q-wave versus Q-wave infarction. Although coronary angioplasty is performed in patients with postinfarction ischemia to alleviate symptoms, the outcome according to location and type of infarction and the effect on prevention of subsequent myocardial infarction and death are not known. To determine if location and type of myocardial infarction provide prognostic information in patients with postinfarction ischemia, we analyzed morbidity and mortality during and after coronary angioplasty according to the location (anterior vs inferior) and type (Q-wave vs non-Q-wave) of myocardial infarction in 505 consecutive patients. The incidence of recurrent angina, repeat coronary angioplasty, coronary bypass surgery, reinfarction, and death during long-term follow-up after hospital discharge (mean 34 +/- 19 months) for the 440 patients with an initial successful angioplasty was also compared. During the procedure, there was no difference in the primary success rate or mortality among the different groups; however, more patients with anterior non-Q-wave myocardial infarction underwent emergent bypass grafting after unsuccessful coronary angioplasty (p = 0.001). Multivariate Cox proportional-hazards analyses controlling for age, gender, number of diseased vessels, location, type of infarction, and year of coronary angioplasty revealed that more patients with anterior infarction had > or = 1 cardiac event (repeat angioplasty, coronary artery bypass grafting, reinfarction, or death) than did those with inferior infarction (RR 1.80, 95% confidence interval [Ci] 1.22 to 2.65, p = 0.003).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7653439     DOI: 10.1016/s0002-9149(99)80125-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Ten year mortality in subsets of patients with an acute coronary syndrome.

Authors:  J Herlitz; B W Karlson; M Sjölin; J Lindqvist
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

2.  Trends in myocardial infarction rates and case fatality by anatomical location in four United States communities, 1987 to 2008 (from the Atherosclerosis Risk in Communities Study).

Authors:  Jonathan D Newman; Daichi Shimbo; Chris Baggett; Xiaoxi Liu; Richard Crow; Joellyn M Abraham; Laura R Loehr; Lisa M Wruck; Aaron R Folsom; Wayne D Rosamond
Journal:  Am J Cardiol       Date:  2013-09-21       Impact factor: 2.778

3.  B-type natriuretic peptide as a predictor of anterior wall location in patients with non-ST-elevation myocardial infarction.

Authors:  Rogério Bicudo Ramos; Célia M Strunz; Solange Desirée Avakian; José Antonio Ramires; Antonio de Padua Mansur
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

4.  Comparing angiography features of inferior versus anterior myocardial infarction regarding severity and extension in a cohort of Iranian patients.

Authors:  Elham Hakki Kazazi; Mehrdad Sheikhvatan; Mehran Mahmoodian; Mahmood Sheikh Fathollahi; Hakimeh Sadeghian
Journal:  J Res Med Sci       Date:  2011-04       Impact factor: 1.852

5.  Effects of Myocardial Perfusion Defect on the Frontal QRS-T Angle in Anterior Versus Inferior Myocardial Infarction.

Authors:  Satoshi Kurisu; Kazuhiro Nitta; Yoji Sumimoto; Hiroki Ikenaga; Ken Ishibashi; Yukihiro Fukuda; Yasuki Kihara
Journal:  Intern Med       Date:  2019-09-11       Impact factor: 1.271

6.  Culprit vessel: impact on short-term and long-term prognosis in patients with ST-elevation myocardial infarction.

Authors:  Artin Entezarjou; Moman Aladdin Mohammad; Pontus Andell; Sasha Koul
Journal:  Open Heart       Date:  2018-09-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.